{"altmetric_id":10367990,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"total":{"posts_count":36},"twitter":{"unique_users_count":30,"unique_users":["jsoriamd","FarmaOnco","TumorImm_papers","Diaceutics","lauravilla88","mjmbauti","DrRaulCordoba","jlariasr","Ablate_Cancer","snovellic","Annals_Oncology","Naomi_OUP","RielyMD","mtmdphd","LungCaNetwork","KadrinWilfong","adrianabello","CICS_DR_MARQUEZ","Francis_Rdgz","Aiims1742","AndyKinley","yingma_maying","SMVImmunology","brunolarvol","kiyotsuguyoshi2","GenomeBiomarker","stuarthenderson","dr_turk","YoungChris27040","FabioSchutz78"],"posts_count":35},"reddit":{"unique_users_count":1,"unique_users":["montaukwhaler"],"posts_count":1}},"selected_quotes":["Path to @US_FDA approval for an #immunotherapy companion diagnostics (by $BMY) #openaccess in @Annals_Oncology #pathologist\u2026","Path to @US_FDA approval for an #immunotherapy companion diagnostics (by $BMY) #openaccess in @Annals_Oncology #pathologists","Does tumor PD-L1 status identify a population deriving greater benefit from PD-1 inhibition than tumors PD-L1neg ?"],"citation":{"abstract":"Chemotherapy combined with radiotherapy is the standard treatment of \"limited-stage\" small-cell lung cancer. However, controversy persists over the optimal timing of thoracic radiotherapy and chemotherapy.\nWe performed a meta-analysis of individual patient data in randomised trials comparing earlier versus later radiotherapy, or shorter vs. longer radiotherapy duration, as defined in each trial. We combined the results from trials using the stratified log-rank test to calculate pooled hazard ratios (HRs). The primary outcome was overall survival.\nTwelve trials with 2,668 patients were eligible. Data from nine trials comprising 2,305 patients were available for analysis. The median follow-up was 10 years. When all trials were analysed together, \"earlier or shorter\" vs. \"later or longer\" thoracic radiotherapy did not affect overall survival. However, the HR for overall survival was significantly in favour of \"earlier or shorter\" radiotherapy among trials with a similar proportion of patients who were compliant with chemotherapy (defined as having received 100% or more of the planned chemotherapy cycles) in both arms (HR 0.79, 95% CI 0.69-0.91) and in favour of \"later or longer\" radiotherapy among trials with different chemotherapy compliance (HR 1.19, 1.05-1.34, interaction test p<0.0001). The absolute gain between \"earlier or shorter\" vs. \"later or longer\" thoracic radiotherapy in 5-year overall survival for similar and for different chemotherapy compliance trials was 7.7% (95% CI 2.6-12.8 %) and -2.2% (-5.8-1.4 %), respectively. However, \"earlier or shorter\" thoracic radiotherapy was associated with a higher incidence of severe acute oesophagitis than \"later or longer\" radiotherapy.\n\"Earlier or shorter\" delivery of thoracic radiotherapy with planned chemotherapy significantly improves 5-year overall survival at the expense of more acute toxicity, especially oesophagitis.","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["J. F. Novotny","J. Cogswell","H. Inzunza","C. Harbison","C. Horak","S. Averbuch","Novotny, J F","Cogswell, J","Inzunza, H","Harbison, C","Horak, C","Averbuch, S","Novotny, J. F.","Cogswell, J.","Inzunza, H.","Harbison, C.","Horak, C.","Averbuch, S."],"doi":"10.1093\/annonc\/mdw288","first_seen_on":"2016-08-10T07:21:42+00:00","funders":["niehs"],"issns":["1569-8041","0923-7534"],"journal":"Annals of Oncology","last_mentioned_on":1505205014,"links":["http:\/\/annonc.oxfordjournals.org\/content\/early\/2016\/08\/06\/annonc.mdw288.short?rss=1","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27502705?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/annonc.oxfordjournals.org\/content\/early\/2016\/08\/06\/annonc.mdw288.full.pdf","http:\/\/annonc.oxfordjournals.org\/content\/early\/2016\/08\/17\/annonc.mdw288.short?rss=1","http:\/\/annonc.oxfordjournals.org\/content\/early\/2016\/08\/31\/annonc.mdw288.short?rss=1","http:\/\/m.annonc.oxfordjournals.org\/content\/27\/10\/1966","http:\/\/annonc.oxfordjournals.org\/content\/27\/10\/1966.full?etoc","https:\/\/academic.oup.com\/annonc\/article\/27\/10\/1966\/2389071\/Establishing-a-complementary-diagnostic-for-anti?searchresult=1"],"pdf_url":"http:\/\/annonc.oxfordjournals.org\/content\/early\/2016\/08\/06\/annonc.mdw288.full.pdf","pmid":"27502705","pubdate":"2016-08-08T00:00:00+00:00","publisher":"Oxford University Press","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"mdw288","subjects":["neoplasms"],"title":"Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy","type":"article","uri":"https:\/\/academic.oup.com\/annonc\/article-lookup\/doi\/10.1093\/annonc\/mdw288","mendeley_url":"http:\/\/www.mendeley.com\/research\/establishing-complementary-diagnostic-antipd1-immune-checkpoint-inhibitor-therapy"},"altmetric_score":{"score":15.7,"score_history":{"1y":12.25,"6m":0.75,"3m":0.75,"1m":0.75,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":15.7},"context_for_score":{"all":{"total_number_of_other_articles":8420753,"mean":7.0857638519611,"rank":561754,"this_scored_higher_than_pct":93,"this_scored_higher_than":7858090,"rank_type":"exact","sample_size":8420753,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":259689,"mean":12.015025961923,"rank":26653,"this_scored_higher_than_pct":89,"this_scored_higher_than":232979,"rank_type":"exact","sample_size":259689,"percentile":89},"this_journal":{"total_number_of_other_articles":3626,"mean":9.7337732413793,"rank":359,"this_scored_higher_than_pct":90,"this_scored_higher_than":3265,"rank_type":"exact","sample_size":3626,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":91,"mean":44.250644444444,"rank":17,"this_scored_higher_than_pct":81,"this_scored_higher_than":74,"rank_type":"exact","sample_size":91,"percentile":81}}},"demographics":{"poster_types":{"member_of_the_public":15,"researcher":7,"practitioner":8},"users":{"twitter":{"cohorts":{"Scientists":7,"Members of the public":15,"Practitioners (doctors, other healthcare professionals)":8}},"mendeley":{"by_status":{"Student  > Ph. D. Student":2,"Other":3,"Student  > Master":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":5,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"twitter":{"ES":3,"ST":1,"US":9,"GB":2,"CA":1,"AU":1},"mendeley":{"GB":1}}},"posts":{"reddit":[{"title":"Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy","url":"http:\/\/www.reddit.com\/r\/nsclc\/comments\/4xpdwk\/establishing_a_complementary_diagnostic_for\/","license":"public","citation_ids":[10367990],"posted_on":"2016-08-14T18:35:40+00:00","author":{"name":"montaukwhaler","url":"http:\/\/www.reddit.com\/r\/nsclc","id_on_source":"nsclc","followers":1,"subreddit":"non small cell lung cancer"}}],"twitter":[{"url":"http:\/\/twitter.com\/jsoriamd\/statuses\/783979185073188864","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-06T10:36:18+00:00","author":{"name":"soria","image":"https:\/\/pbs.twimg.com\/profile_images\/786810335420297216\/3EY8MZsT_normal.jpg","description":"Medical oncologist @gustaveroussy \/ Drug Development Dept Chair \/ Lung cancer specialist\/ Prof @UnivParisSaclay\/ EiC @Annals_Oncology","id_on_source":"jsoriamd","tweeter_id":"525502639","geo":{"lt":null,"ln":null},"followers":2718},"tweet_id":"783979185073188864"},{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/763274033261600768","license":"gnip","citation_ids":[10367990],"posted_on":"2016-08-10T07:21:25+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1681},"tweet_id":"763274033261600768"},{"url":"http:\/\/twitter.com\/TumorImm_papers\/statuses\/763527125903081472","license":"gnip","citation_ids":[10367990],"posted_on":"2016-08-11T00:07:07+00:00","author":{"name":"TumorImmunoPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/741322452093931520\/rQvFtFTA_normal.jpg","description":"A TwitterBot for Cancer Immunology and Tolerance papers on #PubMed. Curated by @adamsnookphd","id_on_source":"TumorImm_papers","tweeter_id":"2829712275","geo":{"lt":null,"ln":null},"followers":659},"tweet_id":"763527125903081472"},{"url":"http:\/\/twitter.com\/Diaceutics\/statuses\/764020617595097088","license":"gnip","rt":["FarmaOnco"],"citation_ids":[10367990],"posted_on":"2016-08-12T08:48:04+00:00","author":{"name":"Diaceutics","url":"http:\/\/www.diaceutics.com","image":"https:\/\/pbs.twimg.com\/profile_images\/829374305926516736\/CI_7XgoT_normal.jpg","description":"We're a group of global experts from the lab, diagnostic & pharmaceutical industries. We help pharma integrate diagnostic testing into their treatment pathways.","id_on_source":"Diaceutics","tweeter_id":"1350757747","geo":{"lt":null,"ln":null},"followers":4102},"tweet_id":"764020617595097088"},{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/769050434233372672","license":"gnip","citation_ids":[10367990],"posted_on":"2016-08-26T05:54:46+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1681},"tweet_id":"769050434233372672"},{"url":"http:\/\/twitter.com\/lauravilla88\/statuses\/769087460777263104","license":"gnip","rt":["FarmaOnco"],"citation_ids":[10367990],"posted_on":"2016-08-26T08:21:54+00:00","author":{"name":"Laura Villaverde","image":"https:\/\/pbs.twimg.com\/profile_images\/902646667475914757\/gJi9wnD4_normal.jpg","description":"Farmac\u00e9utica Especialista en Farmacia Hospitalaria","id_on_source":"lauravilla88","tweeter_id":"1490700282","geo":{"lt":null,"ln":null},"followers":167},"tweet_id":"769087460777263104"},{"url":"http:\/\/twitter.com\/mjmbauti\/statuses\/772339673637199873","license":"gnip","citation_ids":[10367990],"posted_on":"2016-09-04T07:45:02+00:00","author":{"name":"M Jos\u00e9 Mtnz Bautista","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000511842774\/a0e892bb9a9abbfea5a00066859f34dc_normal.jpeg","description":"Farmac\u00e9utica especialista en Farmacia Hospitalaria. Oncology Pharmacist, BCOP. Hospital Universitario Puerta del Mar. C\u00e1diz- SPAIN","id_on_source":"mjmbauti","tweeter_id":"630576233","geo":{"lt":37.18817,"ln":-3.60667,"country":"ES"},"followers":595},"tweet_id":"772339673637199873"},{"url":"http:\/\/twitter.com\/jsoriamd\/statuses\/780480124437266432","license":"gnip","citation_ids":[10367990],"posted_on":"2016-09-26T18:52:16+00:00","author":{"name":"soria","image":"https:\/\/pbs.twimg.com\/profile_images\/786810335420297216\/3EY8MZsT_normal.jpg","description":"Medical oncologist @gustaveroussy \/ Drug Development Dept Chair \/ Lung cancer specialist\/ Prof @UnivParisSaclay\/ EiC @Annals_Oncology","id_on_source":"jsoriamd","tweeter_id":"525502639","geo":{"lt":null,"ln":null},"followers":2718},"tweet_id":"780480124437266432"},{"url":"http:\/\/twitter.com\/DrRaulCordoba\/statuses\/780493704939339776","license":"public","citation_ids":[10367990],"posted_on":"2016-09-26T19:46:14+00:00","author":{"name":"Raul Cordoba","url":"http:\/\/www.fjd.es","image":"https:\/\/pbs.twimg.com\/profile_images\/817087500850229248\/LRpwr7_9_normal.jpg","description":"\ud83c\uddea\ud83c\uddf8Mi Vocaci\u00f3n? La Medicina. Mi Pasi\u00f3n? La Hematolog\u00eda. Mi especialidad? Los Linfomas \ud83c\uddfa\ud83c\uddf8Doctor. Hematologist. Interest in #lymphoma #CLL #gerionc #ImmunoOnc","id_on_source":"DrRaulCordoba","tweeter_id":"1697360292","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":2011},"tweet_id":"780493704939339776"},{"url":"http:\/\/twitter.com\/jlariasr\/statuses\/780495451015512064","license":"public","rt":["DrRaulCordoba"],"citation_ids":[10367990],"posted_on":"2016-09-26T19:53:11+00:00","author":{"name":"Jos\u00e9 Luis Arias","image":"https:\/\/pbs.twimg.com\/profile_images\/419186622895104000\/-oMdCKDn_normal.jpeg","description":"Mejor ser protagonista. No hay caminos rectos hacia los objetivos establecidos - JCC","id_on_source":"jlariasr","tweeter_id":"242457649","geo":{"lt":1,"ln":7,"country":"ST"},"followers":198},"tweet_id":"780495451015512064"},{"url":"http:\/\/twitter.com\/Ablate_Cancer\/statuses\/780553786649481216","license":"public","rt":["DrRaulCordoba"],"citation_ids":[10367990],"posted_on":"2016-09-26T23:44:59+00:00","author":{"name":"$PVCT","url":"http:\/\/www.provectusbio.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/528678090902220800\/fvtFsP4S_normal.png","description":"PV-10 may offer the perfect way to prime the immune system to systematically fight all solid tumor cancers","id_on_source":"Ablate_Cancer","tweeter_id":"2886707502","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":1083},"tweet_id":"780553786649481216"},{"url":"http:\/\/twitter.com\/snovellic\/statuses\/781125533572661248","license":"public","rt":["DrRaulCordoba"],"citation_ids":[10367990],"posted_on":"2016-09-28T13:36:54+00:00","author":{"name":"Silvana Novelli","url":"http:\/\/orcid.org\/0000-0001-8750-0195","image":"https:\/\/pbs.twimg.com\/profile_images\/854575239266742272\/bgVK8qii_normal.jpg","description":"Haematology - H. Sant Pau \u201cIn a gentle way, you can shake the world.\u201d","id_on_source":"snovellic","tweeter_id":"2271979729","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":78},"tweet_id":"781125533572661248"},{"url":"http:\/\/twitter.com\/Annals_Oncology\/statuses\/783701056823955457","license":"gnip","citation_ids":[10367990],"posted_on":"2016-10-05T16:11:07+00:00","author":{"name":"Annals of Oncology","url":"https:\/\/academic.oup.com\/annonc","image":"https:\/\/pbs.twimg.com\/profile_images\/816266349819416576\/zAo22kcV_normal.jpg","description":"Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.","id_on_source":"Annals_Oncology","tweeter_id":"44614314","geo":{"lt":null,"ln":null},"followers":16510},"tweet_id":"783701056823955457"},{"url":"http:\/\/twitter.com\/Naomi_OUP\/statuses\/783976345210646528","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-06T10:25:00+00:00","author":{"name":"Naomi Reeves","url":"http:\/\/www.oupmediainfo.com","image":"https:\/\/pbs.twimg.com\/profile_images\/751060304826605568\/OAmCJELX_normal.jpg","description":"Ad Sales Manager for a great list of scientific and medical journals at OUP. Tea drinker and part of the fab Corporate Sales Team. All views are just me :o)","id_on_source":"Naomi_OUP","tweeter_id":"1487544030","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":98},"tweet_id":"783976345210646528"},{"url":"http:\/\/twitter.com\/RielyMD\/statuses\/783982898873507840","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-06T10:51:03+00:00","author":{"name":"Gregory Riely","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/gregory-riely","image":"https:\/\/pbs.twimg.com\/profile_images\/417048782061072384\/_0a_yv3o_normal.jpeg","description":"Medical Oncologist at Memorial Sloan Kettering Cancer Center.  Clinical focus on lung and thymic malignancies","id_on_source":"RielyMD","tweeter_id":"301164011","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1721},"tweet_id":"783982898873507840"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/784017320486109185","license":"public","citation_ids":[10367990],"posted_on":"2016-10-06T13:07:50+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15376},"tweet_id":"784017320486109185"},{"url":"http:\/\/twitter.com\/LungCaNetwork\/statuses\/784017723479252994","license":"public","rt":["mtmdphd"],"citation_ids":[10367990],"posted_on":"2016-10-06T13:09:26+00:00","author":{"name":"CRAB Clinical Trials","url":"http:\/\/www.crabctc.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550375924865064961\/9iGmcgEA_normal.png","description":"CRAB CTC aims to provide an international network to rapidly translate novel agents into new treatments for lung cancer.","id_on_source":"LungCaNetwork","tweeter_id":"361490128","geo":{"lt":null,"ln":null},"followers":454},"tweet_id":"784017723479252994"},{"url":"http:\/\/twitter.com\/KadrinWilfong\/statuses\/784130857472815104","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-06T20:38:59+00:00","author":{"name":"Kadrin Wilfong, MD","url":"http:\/\/peerviewpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/860644063535439873\/t7XiW_Zj_normal.jpg","description":"Senior Medical Director at PVI, PeerView Institute for Medical Education (follow @PeerView); Advocate for participatory medicine","id_on_source":"KadrinWilfong","tweeter_id":"81732297","geo":{"lt":null,"ln":null},"followers":1130},"tweet_id":"784130857472815104"},{"url":"http:\/\/twitter.com\/adrianabello\/statuses\/784131153540288513","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-06T20:40:10+00:00","author":{"name":"Adriana Bello","image":"https:\/\/pbs.twimg.com\/profile_images\/897315894661087236\/OKflFC98_normal.jpg","description":"pediatrician, pediatric hematologyst, mother adribello@hotmail.com","id_on_source":"adrianabello","tweeter_id":"56900138","geo":{"lt":null,"ln":null},"followers":1267},"tweet_id":"784131153540288513"},{"url":"http:\/\/twitter.com\/CICS_DR_MARQUEZ\/statuses\/784242945171992576","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-07T04:04:23+00:00","author":{"name":"CICS Sonora & USA","url":"http:\/\/www.cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907387845605711872\/7EFMUd95_normal.jpg","description":"We are Physician Scientists performing clinically relevant oncology research for childhood & adult cancer. We belong to the binational IMMUNOONCOLOGY alliance.","id_on_source":"CICS_DR_MARQUEZ","tweeter_id":"744606863224774656","geo":{"lt":null,"ln":null},"followers":2510},"tweet_id":"784242945171992576"},{"url":"http:\/\/twitter.com\/Francis_Rdgz\/statuses\/784425808894959616","license":"gnip","rt":["Annals_Oncology"],"citation_ids":[10367990],"posted_on":"2016-10-07T16:11:01+00:00","author":{"name":"@CICS_Mtra_Francis","image":"https:\/\/pbs.twimg.com\/profile_images\/869247591409569792\/ZJHCCZh7_normal.jpg","description":"Hello, I'm the General Director of the Sonora Cancer Research Center (CICS). I'm happy to contribute in Cancer projects with clinical relevance.","id_on_source":"Francis_Rdgz","tweeter_id":"747459371735494656","geo":{"lt":null,"ln":null},"followers":628},"tweet_id":"784425808894959616"},{"url":"http:\/\/twitter.com\/jsoriamd\/statuses\/829747836870881281","license":"gnip","citation_ids":[10367990],"posted_on":"2017-02-09T17:44:34+00:00","author":{"name":"soria","image":"https:\/\/pbs.twimg.com\/profile_images\/786810335420297216\/3EY8MZsT_normal.jpg","description":"Medical oncologist @gustaveroussy \/ Drug Development Dept Chair \/ Lung cancer specialist\/ Prof @UnivParisSaclay\/ EiC @Annals_Oncology","id_on_source":"jsoriamd","tweeter_id":"525502639","geo":{"lt":null,"ln":null},"followers":2718},"tweet_id":"829747836870881281"},{"url":"http:\/\/twitter.com\/Aiims1742\/statuses\/829749581835595777","license":"gnip","citation_ids":[10367990],"posted_on":"2017-02-09T17:51:30+00:00","author":{"name":"Anirban Maitra","url":"https:\/\/www.mdanderson.org\/research\/departments-labs-institutes\/labs\/maitra-laboratory.html","image":"https:\/\/pbs.twimg.com\/profile_images\/884178778842443781\/KdCPRIXj_normal.jpg","description":"Scientific Director of the Ahmed Center for Pancreatic Cancer Research at MD Anderson Cancer Ctr. Also a GI Pathologist. Tweets & opinions expressed are my own.","id_on_source":"Aiims1742","tweeter_id":"166816694","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":4905},"tweet_id":"829749581835595777"},{"url":"http:\/\/twitter.com\/Ablate_Cancer\/statuses\/829750849991647232","license":"gnip","rt":["Aiims1742"],"citation_ids":[10367990],"posted_on":"2017-02-09T17:56:33+00:00","author":{"name":"$PVCT","url":"http:\/\/www.provectusbio.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/528678090902220800\/fvtFsP4S_normal.png","description":"PV-10 may offer the perfect way to prime the immune system to systematically fight all solid tumor cancers","id_on_source":"Ablate_Cancer","tweeter_id":"2886707502","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":1083},"tweet_id":"829750849991647232"},{"url":"http:\/\/twitter.com\/AndyKinley\/statuses\/829764064448503809","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-09T18:49:03+00:00","author":{"name":"Andy Kinley","image":"https:\/\/pbs.twimg.com\/profile_images\/596045156710621184\/ziJrjLJc_normal.jpg","description":"Oncology clinical researcher, former scientist, cancer cell signaling, bias hunting, mountain biking in Blue Ridge Mtns","id_on_source":"AndyKinley","tweeter_id":"478902310","geo":{"lt":38.02931,"ln":-78.47668,"country":"US"},"followers":304},"tweet_id":"829764064448503809"},{"url":"http:\/\/twitter.com\/yingma_maying\/statuses\/829764930228338692","license":"gnip","rt":["Aiims1742"],"citation_ids":[10367990],"posted_on":"2017-02-09T18:52:30+00:00","author":{"name":"Ying Ma","url":"http:\/\/www.scopus.com\/authid\/detail.url?authorId=55790985600","image":"https:\/\/pbs.twimg.com\/profile_images\/533757055308288000\/CeKZT7Sn_normal.jpeg","description":"Immunologist\/pathologist on pancreatic cancer research at UT MD Anderson Cancer Center. \nhttps:\/\/www.linkedin.com\/in\/ying-ma-0691b448\/","id_on_source":"yingma_maying","tweeter_id":"2900926058","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":59},"tweet_id":"829764930228338692"},{"url":"http:\/\/twitter.com\/SMVImmunology\/statuses\/829772536275730434","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-09T19:22:43+00:00","author":{"name":"Saman Maleki, PhD","url":"http:\/\/samanmaleki.blogspot.ca\/","image":"https:\/\/pbs.twimg.com\/profile_images\/865578727203381248\/K582B1rK_normal.jpg","description":"Tumor Immunologist and Cancer Biologist @lawsonresearch. Advocate for Cancer Immunotherapy. Views are my own. Retweets or likes are not endorsement.","id_on_source":"SMVImmunology","tweeter_id":"397025602","geo":{"lt":42.98339,"ln":-81.23304,"country":"CA"},"followers":772},"tweet_id":"829772536275730434"},{"url":"http:\/\/twitter.com\/brunolarvol\/statuses\/829798601387864065","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-09T21:06:18+00:00","author":{"name":"Bruno Larvol","url":"http:\/\/www.larvol.com","image":"https:\/\/pbs.twimg.com\/profile_images\/870820480197861376\/wJd9yafJ_normal.jpg","description":"interested in how tech allows for radical new types of orgs, #pharma #biotech #SaaS #AI @larvol","id_on_source":"brunolarvol","tweeter_id":"2418052297","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":777},"tweet_id":"829798601387864065"},{"url":"http:\/\/twitter.com\/CICS_DR_MARQUEZ\/statuses\/829805614914170880","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-09T21:34:10+00:00","author":{"name":"CICS Sonora & USA","url":"http:\/\/www.cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907387845605711872\/7EFMUd95_normal.jpg","description":"We are Physician Scientists performing clinically relevant oncology research for childhood & adult cancer. We belong to the binational IMMUNOONCOLOGY alliance.","id_on_source":"CICS_DR_MARQUEZ","tweeter_id":"744606863224774656","geo":{"lt":null,"ln":null},"followers":2510},"tweet_id":"829805614914170880"},{"url":"http:\/\/twitter.com\/kiyotsuguyoshi2\/statuses\/829831881688354816","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-09T23:18:32+00:00","author":{"name":"\u30e8\u30c3\u30b7\u30fc","image":"https:\/\/pbs.twimg.com\/profile_images\/716999221375709184\/YYOpmYfx_normal.jpg","description":"MD, Basic Researcher & Artist","id_on_source":"kiyotsuguyoshi2","tweeter_id":"714431915965571072","geo":{"lt":null,"ln":null},"followers":78},"tweet_id":"829831881688354816"},{"url":"http:\/\/twitter.com\/GenomeBiomarker\/statuses\/830076151338905600","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-10T15:29:11+00:00","author":{"name":"Martha Li","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000457990683\/9e3c4d48d549fcf54f5fe33341dcb0b2_normal.jpeg","description":"Developing companion diagnostics for oncology drugs.","id_on_source":"GenomeBiomarker","tweeter_id":"1865054702","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":177},"tweet_id":"830076151338905600"},{"url":"http:\/\/twitter.com\/stuarthenderson\/statuses\/830085247106744321","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-10T16:05:19+00:00","author":{"name":"stuarthenderson","image":"https:\/\/pbs.twimg.com\/profile_images\/771715429\/DSC_0043_normal.JPG","description":"Managing Director @Accenture. All tweets represent my opinions and not my employer.","id_on_source":"stuarthenderson","tweeter_id":"18300732","geo":{"lt":40.34872,"ln":-74.65905,"country":"US"},"followers":298},"tweet_id":"830085247106744321"},{"url":"http:\/\/twitter.com\/dr_turk\/statuses\/833085980693450752","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-02-18T22:49:10+00:00","author":{"name":"Richard Turkington","image":"https:\/\/pbs.twimg.com\/profile_images\/855854927243096065\/eujoX67v_normal.jpg","description":"Husband, dad of two wee men, oncologist and cancer researcher #Oesophageal #Gastric #Pancreatic Cancer","id_on_source":"dr_turk","tweeter_id":"374658111","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":252},"tweet_id":"833085980693450752"},{"url":"http:\/\/twitter.com\/YoungChris27040\/statuses\/907517407920406530","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-09-12T08:13:05+00:00","author":{"name":"Chris Young","url":"https:\/\/m.facebook.com\/home.php?soft=bookmarks","image":"https:\/\/pbs.twimg.com\/profile_images\/832595198987296769\/VjFKip8q_normal.jpg","description":"Advocate #equality #disabilities #health LT #investor \ud83d\udd0eP-value mrkt intel\" #Biotech paradigm-shift research, pre-eminently humane. retweets not endorsements.","id_on_source":"YoungChris27040","tweeter_id":"1415149603","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":1405},"tweet_id":"907517407920406530"},{"url":"http:\/\/twitter.com\/FabioSchutz78\/statuses\/907521723360309249","license":"gnip","rt":["jsoriamd"],"citation_ids":[10367990],"posted_on":"2017-09-12T08:30:14+00:00","author":{"name":"Fabio Schutz","image":"https:\/\/pbs.twimg.com\/profile_images\/870023146514132992\/p2bRqnx1_normal.jpg","description":"Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer","id_on_source":"FabioSchutz78","tweeter_id":"870017969136467969","geo":{"lt":null,"ln":null},"followers":381},"tweet_id":"907521723360309249"}]}}